Creating Fast and Safe Tests for Viruses like COVID-19
Development of Safe and Rapid Reporter Viruses for Studying Pathogenic and Pandemic Viruses
This project aims to create a quicker and safer lab test to measure how well antibodies protect against viruses, including those that cause pandemics.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Integral Molecular NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11124869 on NIH RePORTER |
What this research studies
Current methods for checking how well our bodies fight off viruses, especially after vaccination, can be slow and difficult to perform safely with dangerous viruses. This project is developing a new, faster, and safer lab test called a Rapid Reporter Virus (RRV). This new test will help scientists quickly see how effective vaccines or treatments are by measuring the body's protective response. The goal is to make it easier and quicker to test many samples, which is crucial during large-scale vaccine development.
Who could benefit from this research
Good fit: This project does not directly involve patient participation, but its results could benefit anyone who might need vaccines or treatments for viral infections, especially during pandemics.
Not a fit: Patients seeking direct clinical care or immediate treatment options would not directly benefit from this laboratory tool development.
Why it matters
Potential benefit: If successful, this new test could significantly speed up the development and testing of vaccines and antiviral treatments for dangerous viruses, leading to faster protection for communities.
How similar studies have performed: While traditional methods exist, this project aims to create a novel, more streamlined, and safer assay that improves upon existing reporter virus technologies.
Where this research is happening
Philadelphia, United States
- Integral Molecular — Philadelphia, United States (Active)
Researchers
- Principal investigator: Doranz, Benjamin J — Integral Molecular
- Study coordinator: Doranz, Benjamin J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.